Evolution and prospects for the definition of clinically useful endpoints in Sjögren disease

A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease

Activity and Damage Indices for Sjögren's Disease

Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group

OMERACT- determining a core domain set for Sjögren's disease: International focus group series

Is Sjögren's disease the overlooked connective tissue disease associated with a hypersensitivity pneumonitis pattern?

Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)

Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren's Disease and Association with Patient-Reported Outcomes

Association between anti-SSA/SSB antibody profiles and patient-reported outcomes in primary Sjögren's disease

A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials

Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data

Impact of Sjögren's disease on quality of sexual life using the Qualisex score

Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group

Epidemiology of Sjögren syndrome

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

Characterisation of airway disease associated with Sjögren disease

Conception in women with primary Sjögren's disease

Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease

Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study

Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)

The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation

Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort

Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort

Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study

Stability and prognostic value of B-cell markers in primary SS: results from the French ASSESS cohort

Diagnostic accuracy of (18)F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP)

French recommendations for the use of imaging in giant cell arteritis

Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies

Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

French protocol for the diagnosis and management of giant cell arteritis

Association between antibiotic use and the onset of giant cell arteritis and polymyalgia rheumatica: A nested case-control study from E3N-European Prospective Investigation into Cancer and Nutrition

Molecular profiling and risk stratification in solitary bone plasmacytoma

French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases

Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis

High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fracture

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica

[(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects

2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis

Cancer risk associated with abatacept among older individuals with rheumatoid arthritis in the United States

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort study

Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum

Treatment of mixed connective tissue disease: A multicenter retrospective study

Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort

Early-life animal and farming exposures and the risk of rheumatoid arthritis: findings from the E3N French cohort study

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases

Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis

Cardiovascular risk among Giant cells arteritis patients

Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database

Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature

Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database